Biomarin Pharmaceutical Inc (BMRN) · Fund holders
Which of the 64 well-known fund managers followed here own Biomarin Pharmaceutical, from the 13F each files after a quarter's end, and what each did in its latest quarter.
Held by
4
of 64 funds
Their stake
$1.30B
together
Bought
3
0 new, 3 added
Sold
2
1 sold out
The funds
| Fund | Share of its portfolio | Shares | Value | Latest quarter |
|---|---|---|---|---|
| Dodge & Cox2026-06-30 | 0.44% | 14,844,930 | $849.43M | Added 2% |
| Viking Global Investors2026-06-30 | 1.24% | 7,616,563 | $435.82M | Added 8% |
| Bridgewater Associates2026-06-30 | 0.06% | 274,911 | $15.73M | Added 33% |
| Gotham Asset Management (Joel Greenblatt)2026-06-30 | 0.00% | 28,641 | $1.64M | Reduced 84% |
| Point72 Asset Management (Steve Cohen)2026-06-30 | 0.00% | 0 | – | Sold out |
A 13F shows a quarter's end and is filed up to 45 days later, so this is not what the funds hold today. All funds ›